Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.258.24EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.258.24EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.258.24ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.258.24ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.160.11EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.160.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.11ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.160.11ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.160.11EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.160.11EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.160.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.160.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.160.10EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.160.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
B.1.160.10ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.160.10ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-3196.01Germany
B.1.160.10EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-3064.43China
B.1.160.10EHuang-EGCAGCAGTACGCACACAATC20552637626357R-3384China
B.1.160.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
B.1.160.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
B.1.177.71EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177.71EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
B.1.177.71ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.177.71ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-3196.01Germany
B.1.177.71EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-1339.23China
B.1.177.71EHuang-EGCAGCAGTACGCACACAATC20552637626357R-3384China
B.1.177.71ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-1427.97China
B.1.177.71ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
B.1.260EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.260EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.260ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.260ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.260EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.260EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.260ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.260ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.456EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.456EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.456ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.456ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.456EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.456EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.456ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.456ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.160.16EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.160.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.16ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.160.16ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.160.16EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.160.16EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used